<VariationArchive VariationID="2018541" VariationName="NM_001347721.2(DYRK1A):c.1587_1588dup (p.Gly530fs)" VariationType="Duplication" Accession="VCV002018541" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2072624" VariationID="2018541">
      <GeneList>
        <Gene Symbol="DYRK1A" FullName="dual specificity tyrosine phosphorylation regulated kinase 1A" GeneID="1859" HGNC_ID="HGNC:3091" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>21q22.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="37365573" stop="37526358" display_start="37365573" display_stop="37526358" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="38739858" stop="38887678" display_start="38739858" display_stop="38887678" Strand="+" />
          </Location>
          <OMIM>600855</OMIM>
          <Haploinsufficiency last_evaluated="2020-12-16" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DYRK1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-12-16" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DYRK1A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001347721.2(DYRK1A):c.1587_1588dup (p.Gly530fs)</Name>
      <CanonicalSPDI>NC_000021.9:37506164:GTG:GTGTG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>21q22.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="37506164" stop="37506165" display_start="37506164" display_stop="37506165" variantLength="2" positionVCF="37506164" referenceAlleleVCF="A" alternateAlleleVCF="AGT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="38878467" stop="38878468" display_start="38878467" display_stop="38878468" variantLength="2" positionVCF="38878467" referenceAlleleVCF="A" alternateAlleleVCF="AGT" />
      </Location>
      <ProteinChange>G539fs</ProteinChange>
      <ProteinChange>G501fs</ProteinChange>
      <ProteinChange>G530fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.8" sequenceAccession="NC_000021" sequenceVersion="8" change="g.38878469_38878470dup" Assembly="GRCh37">
            <Expression>NC_000021.8:g.38878469_38878470dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.9" sequenceAccession="NC_000021" sequenceVersion="9" change="g.37506166_37506167dup" Assembly="GRCh38">
            <Expression>NC_000021.9:g.37506166_37506167dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009366.1" sequenceAccession="NG_009366" sequenceVersion="1" change="g.143611_143612dup">
            <Expression>NG_009366.1:g.143611_143612dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009366.2" sequenceAccession="NG_009366" sequenceVersion="2" change="g.145595_145596dup">
            <Expression>NG_009366.2:g.145595_145596dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001347721.2" sequenceAccession="NM_001347721" sequenceVersion="2" change="c.1587_1588dup" MANESelect="true">
            <Expression>NM_001347721.2:c.1587_1588dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334650.1" sequenceAccession="NP_001334650" sequenceVersion="1" change="p.Gly530fs">
            <Expression>NP_001334650.1:p.Gly530fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001347722.2" sequenceAccession="NM_001347722" sequenceVersion="2" change="c.1587_1588dup">
            <Expression>NM_001347722.2:c.1587_1588dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334651.1" sequenceAccession="NP_001334651" sequenceVersion="1" change="p.Gly530fs">
            <Expression>NP_001334651.1:p.Gly530fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001347723.2" sequenceAccession="NM_001347723" sequenceVersion="2" change="c.1500_1501dup">
            <Expression>NM_001347723.2:c.1500_1501dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334652.1" sequenceAccession="NP_001334652" sequenceVersion="1" change="p.Gly501fs">
            <Expression>NP_001334652.1:p.Gly501fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001396.5" sequenceAccession="NM_001396" sequenceVersion="5" change="c.1614_1615dup">
            <Expression>NM_001396.5:c.1614_1615dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001387.2" sequenceAccession="NP_001387" sequenceVersion="2" change="p.Gly539fs">
            <Expression>NP_001387.2:p.Gly539fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_101395.2" sequenceAccession="NM_101395" sequenceVersion="2" change="c.1614_1615dup">
            <Expression>NM_101395.2:c.1614_1615dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_567824.1" sequenceAccession="NP_567824" sequenceVersion="1" change="p.Gly539fs">
            <Expression>NP_567824.1:p.Gly539fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130436.2" sequenceAccession="NM_130436" sequenceVersion="2" change="c.1587_1588dup">
            <Expression>NM_130436.2:c.1587_1588dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_569120.1" sequenceAccession="NP_569120" sequenceVersion="1" change="p.Gly530fs">
            <Expression>NP_569120.1:p.Gly530fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130438.2" sequenceAccession="NM_130438" sequenceVersion="2" change="c.1546+577_1546+578dup">
            <Expression>NM_130438.2:c.1546+577_1546+578dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001347721.2(DYRK1A):c.1587_1588dup (p.Gly530fs) AND DYRK1A-related intellectual disability syndrome" Accession="RCV002862062" Version="2">
        <ClassifiedConditionList TraitSetID="7564">
          <ClassifiedCondition DB="MedGen" ID="C5568143">DYRK1A-related intellectual disability syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-07-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-07-21" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="7564" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16137" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">DYRK1A-related intellectual disability syndrome</ElementValue>
                <XRef ID="MONDO:0013578" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 7</ElementValue>
                <XRef Type="MIM" ID="614104" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600855.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600855.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600855.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600855.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600855.0001" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MRD7</ElementValue>
                <XRef Type="MIM" ID="614104" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">DYRK1A syndrome is characterized by intellectual disability including impaired speech development, autism spectrum disorder including anxious and/or stereotypic behavior problems, and microcephaly. Affected individuals often have a clinically recognizable phenotype including a typical facial gestalt, feeding problems, seizures, hypertonia, gait disturbances, and foot anomalies. The majority of affected individuals function in the moderate-to-severe range of intellectual disability; however, individuals with mild intellectual disability have also been reported. Other medical concerns relate to febrile seizures in infancy; the development of epilepsy with seizures of the atonic, absence, and generalized myoclonic types; short stature; and gastrointestinal problems. Ophthalmologic, urogenital, cardiac, and/or dental anomalies have been reported.</Attribute>
                <XRef ID="NBK333438" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13527" />
                <XRef ID="13527" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">26677511</ID>
                <ID Source="BookShelf">NBK333438</ID>
              </Citation>
              <XRef ID="464306" DB="Orphanet" />
              <XRef ID="C5568143" DB="MedGen" />
              <XRef ID="MONDO:0013578" DB="MONDO" />
              <XRef Type="MIM" ID="614104" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5911956" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="17139279|MedGen:C3279839" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003223111" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant has not been reported in the literature in individuals affected with DYRK1A-related conditions. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the DYRK1A protein in which other variant(s) (p.Gln576*) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gly539Valfs*54) in the DYRK1A gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 225 amino acid(s) of the DYRK1A protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DYRK1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000021.8:g.38878467_38878468insGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3279839" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5911956" TraitType="Disease" MappingType="XRef" MappingValue="C3279839" MappingRef="MedGen">
        <MedGen CUI="C5568143" Name="DYRK1A-related intellectual disability syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

